Cell & Gene Therapy In Vivo CAR-T Webinar | Industrialization of In Vivo CAR-T Therapy Development | ProBio CDMO 12-02-2025 / Chunling Xuan Director, LVV PD, ProBio;Jiang Xu Head of LNP formulation, ProBio; CAR-T therapies have revolutionized blood cancer treatment, but traditional ex vivo manufacturing remains costly and time-consuming. Next-generation in vivo CAR-T is set to change the game, driven by two delivery platforms: LVV (viral) and LNP...... Learn More
Cell & Gene Therapy AAV Webinar | Design, Build & Scale AAV Discovery to Process Development | ProBio CDMO 08-26-2025 / Cheng Luo, Director of Pharmacology Dept., ProBio Adeno-associated viruses (AAVs) are widely used in gene therapy for its safety and ability to support long-term gene expression. Learn More
Cell & Gene Therapy LVV Webinar | From DNA to Therapy: Plasmid & LVV Insights | ProBio CDMO 04-22-2025 / Luffy Chen, Head of Plasmid PD and Production Dept., ProBio Join us on April 22ⁿᵈ for an exclusive webinar on Cell and Gene Therapy (CGT) development! Gain expert knowledge on optimizing plasmid and LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications... Learn More
Cell & Gene Therapy Strategies and Solutions for mRNA Therapeutics and Personalized Medicines | ProBio CDMO 05-23-2024 / Dr. Xiao Pan, Director of Platform R&D Dept. Learn More
Cell & Gene Therapy Unlocking Affordability: Cell Therapy Development Strategies to Expand Patient Access | ProBio CDMO 03-28-2024 / Dr. Li Chen, Sr. Director, Biologics Discovery Dept. ProBio VHH is a novel modality in antibody based therapy. Its naturally generated single-domain structure makes it an ideal building block in cell therapy. Learn More
Cell & Gene Therapy mRNA One-stop Solution: Plasmid, Linearized DNA, IVT-mRNA, mRNA-LNP and QC sharing | ProBio CDMO 09-05-2023 / Dr. Xiao Pan, Sr. Director, Platform R&D Dept. The production of mRNA therapeutics and vaccines is a complex process that begins with pDNA manufacturing and ends with fill and finish by using different delivery technologies. Learn More
Cell & Gene Therapy Integrated one-stop solution for mRNA CMC | ProBio CDMO 03-28-2023 / Dr. Xiao Pan, Director of Platform R&D Dept., ProBio The production of mRNA therapeutics and vaccines is a complex process that begins with pDNA manufacturing and ends with fill and finish by using different delivery technologies. Currently, there are some mRNA candidates in late-stage trials or commercial Learn More
Cell & Gene Therapy Addressing analytical control challenges for different plasmid DNA products | ProBio CDMO 11-30-2022 / Lauren Lu, Senior Director of QC Dept Addressing analytical control challenges for different plasmid DNA products Learn More